Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Daiichi Sankyo Wins Patent Case Against Mylan

By Drug Discovery Trends Editor | September 10, 2010

Daiichi Sankyo Company, Limited announced that the United States Court of Appeals for the Federal Circuit has affirmed the U.S. District Court decision in patent litigation against Mylan, upholding the validity of the Daiichi Sankyo U.S. patent covering Benicar, Benicar HCT, and AZOR. Daiichi Sankyo initiated litigation against Mylan in response to Abbreviated New Drug Applications filed by Mylan seeking to market generic versions of Benicar, Benicar HCT and AZOR before the expiration of the Daiichi Sankyo patent, which expires in 2016.

The litigation involves the Daiichi Sankyo U.S. patent covering olmesartan medoxomil, the active ingredient in Benicar, Benicar HCT, and AZOR. Independently developed by Daiichi Sankyo, olmesartan medoxomil is an angiotensin II receptor antagonist that suppresses vasoconstriction to control blood pressure. Products containing olmesartan medoxomil are marketed in more than 60 countries as treatments for hypertension.

Date: September 10, 2010
Source: Daiichi Sankyo Company, Limited 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50